Literature DB >> 17918777

Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging.

Christian T Farrar1, Guangping Dai, Mikhail Novikov, Anthony Rosenzweig, Ralph Weissleder, Bruce R Rosen, David E Sosnovik.   

Abstract

Off-resonance imaging (ORI) techniques are being increasingly used to image iron oxide imaging agents such as monocrystalline iron oxide nanoparticles (MION). However, the diagnostic accuracy, linearity, and field dependence of ORI have not been fully characterized. In this study, the sensitivity, specificity, and linearity of ORI were thus examined as a function of both MION concentration and magnetic field strength (4.7 and 14 T). MION phantoms with and without an air interface as well as MION uptake in a mouse model of healing myocardial infarction were imaged. MION-induced resonance shifts were shown to increase linearly with MION concentration. In contrast, the ORI signal/sensitivity was highly non-linear, initially increasing with MION concentration until T2 became comparable to the TE and decreasing thereafter. The specificity of ORI to distinguish MION-induced resonance shifts from on-resonance water was found to decrease with increasing field because of the increased on-resonance water linewidths (15 Hz at 4.7 T versus 45 Hz at 14 T). Large resonance shifts ( approximately 300 Hz) were observed at air interfaces at 4.7 T, both in vitro and in vivo, and led to poor ORI specificity for MION concentrations less than 150 microg Fe/mL. The in vivo ORI sensitivity was sufficient to detect the accumulation of MION in macrophages infiltrating healing myocardial infarcts, but the specificity was limited by non-specific areas of positive contrast at the air/tissue interfaces of the thoracic wall and the descending aorta. Improved specificity and linearity can, however, be expected at lower fields where decreased on-resonance water linewidths, reduced air-induced resonance shifts, and longer T2 relaxation times are observed. The optimal performance of ORI will thus likely be seen at low fields, with moderate MION concentrations and with sequences containing very short TEs. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17918777      PMCID: PMC2629945          DOI: 10.1002/nbm.1209

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  28 in total

1.  In vivo magnetic resonance imaging of transgene expression.

Authors:  R Weissleder; A Moore; U Mahmood; R Bhorade; H Benveniste; E A Chiocca; J P Basilion
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

2.  Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles.

Authors:  Patrick Wunderbaldinger; Lee Josephson; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2002 Mar-Apr       Impact factor: 4.774

3.  Passive tracking exploiting local signal conservation: the white marker phenomenon.

Authors:  Jan-Henry Seppenwoolde; Max A Viergever; Chris J G Bakker
Journal:  Magn Reson Med       Date:  2003-10       Impact factor: 4.668

4.  Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells.

Authors:  Chris V Bowen; Xiaowei Zhang; George Saab; Paula J Gareau; Brian K Rutt
Journal:  Magn Reson Med       Date:  2002-07       Impact factor: 4.668

5.  Magnetic relaxation switches capable of sensing molecular interactions.

Authors:  J Manuel Perez; Lee Josephson; Terrence O'Loughlin; Dagmar Högemann; Ralph Weissleder
Journal:  Nat Biotechnol       Date:  2002-07-22       Impact factor: 54.908

6.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

Authors:  M Lewin; N Carlesso; C H Tung; X W Tang; D Cory; D T Scadden; R Weissleder
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

7.  Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct.

Authors:  Matthias Nahrendorf; David E Sosnovik; Peter Waterman; Filip K Swirski; Ashvin N Pande; Elena Aikawa; Jose-Luiz Figueiredo; Mikael J Pittet; Ralph Weissleder
Journal:  Circ Res       Date:  2007-03-22       Impact factor: 17.367

8.  Imaging single mammalian cells with a 1.5 T clinical MRI scanner.

Authors:  Paula Foster-Gareau; Chris Heyn; Andrew Alejski; Brian K Rutt
Journal:  Magn Reson Med       Date:  2003-05       Impact factor: 4.668

9.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

Authors:  Mukesh G Harisinghani; Jelle Barentsz; Peter F Hahn; Willem M Deserno; Shahin Tabatabaei; Christine Hulsbergen van de Kaa; Jean de la Rosette; Ralph Weissleder
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

Authors:  Joseph A Frank; Brad R Miller; Ali S Arbab; Holly A Zywicke; E Kay Jordan; Bobbi K Lewis; L Henry Bryant; Jeff W M Bulte
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

View more
  30 in total

Review 1.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

2.  Combined off-resonance imaging and T2 relaxation in the rotating frame for positive contrast MR imaging of infection in a murine burn model.

Authors:  Ovidiu C Andronesi; Dionyssios Mintzopoulos; Valeria Righi; Nikolaos Psychogios; Meenu Kesarwani; Jianxin He; Shingo Yasuhara; George Dai; Laurence G Rahme; Aria A Tzika
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

3.  Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification.

Authors:  Daniel Jirak; Jan Kriz; Michal Strzelecki; Jiabi Yang; Craig Hasilo; David J White; Paula J Foster
Journal:  MAGMA       Date:  2009-04-24       Impact factor: 2.310

Review 4.  Molecular imaging in cardiovascular magnetic resonance imaging: current perspective and future potential.

Authors:  David E Sosnovik
Journal:  Top Magn Reson Imaging       Date:  2008-02

5.  Labelling of mammalian cells for visualisation by MRI.

Authors:  Monique R Bernsen; Amber D Moelker; Piotr A Wielopolski; Sandra T van Tiel; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2009-08-12       Impact factor: 5.315

6.  Science to practice: how will myocardial inflammation be imaged with MR imaging?

Authors:  David E Sosnovik; Matthias Nahrendorf; Peter Caravan
Journal:  Radiology       Date:  2012-08       Impact factor: 11.105

7.  Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents.

Authors:  David E Sosnovik; Peter Caravan
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-04-01

Review 8.  Detection and quantification of magnetically labeled cells by cellular MRI.

Authors:  Wei Liu; Joseph A Frank
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

Review 9.  Multimodal iron oxide nanoparticles for hybrid biomedical imaging.

Authors:  Timo Heidt; Matthias Nahrendorf
Journal:  NMR Biomed       Date:  2012-10-15       Impact factor: 4.044

Review 10.  Optical and multimodality molecular imaging: insights into atherosclerosis.

Authors:  Farouc A Jaffer; Peter Libby; Ralph Weissleder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-09       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.